You might wonder what Cantor Fitzgerald analyst Pablo Zuanic is smoking. There's no question that Zuanic has been one of the biggest bulls for Aurora Cannabis (NYSE: ACB) for quite a while. After Aurora's trainwreck of a quarterly update in November, he upgraded the stock while other analysts were cutting their ratings. It seems that regardless of what happens with Aurora, Zuanic's optimism remains largely intact.
While Cowen analyst Vivien Azer just downgraded Aurora Cannabis, Zuanic continues to give the stock an overweight rating (equivalent to a buy recommendation). He even boosted his one-year price target for Aurora to 3.80 Canadian dollars from CA$3.75, reflecting upside of around 85% from the current share price. Could Zuanic actually be right about Aurora?
Image source: Getty Images.